Cervical cancer (CC) was diagnosed in 3159 women in France in 2023, and 1117 died from it. Organized screening for cervical cancer is potentially very effective for participating women. However, reaching under-screened populations remains a major challenge. The present qualitative study explored women’s opinions on what discourages or encourages them to participate in CC screening and assessed the acceptability of two experimental strategies (urinary or vaginal self-sampling kits) to increase the screening coverage in three rural French administrative departments with low medical density and/or low screening participation rates. Forty-eight semi-structured interviews and four focus groups were conducted by a team of psychologists. Results showed that the participants accepted at-home self-sampling to reach non-participating women in medically underserved areas. However, they suggested that the type of kit sent should be adapted to the patient’s profile (embarrassment from earlier exams, cultural aspects, fear of invasiveness, etc.), and that kits should be simple to use (in understandable language taking sociocultural aspects into account). Women wished to be assured that testing on self-samples is accurate and needed information about further actions in case of a positive result.
2023年法国共有3159名女性被诊断出宫颈癌，其中1117人因此死亡。对于参与筛查的女性而言，有组织的宫颈癌筛查具有显著成效。然而，如何覆盖筛查不足的人群仍是重大挑战。本定性研究通过探讨女性对参与宫颈癌筛查的阻碍与促进因素，评估了两种实验性策略（尿液或阴道自采样工具包）在法国三个医疗资源匮乏和/或筛查参与率较低的农村行政区的接受度。由心理学团队开展的48次半结构化访谈和4次焦点小组讨论显示：参与者认可通过居家自采样方式覆盖医疗服务不足地区的未筛查女性，但建议应根据个体特征（如既往检查的尴尬体验、文化因素、对侵入性操作的恐惧等）适配采样工具类型，并确保工具操作简便（使用兼顾社会文化因素的可理解语言）。女性群体希望获得自采样检测准确性的保证，并需要了解检测结果阳性后的后续措施信息。
肿瘤(癌症)患者之家